About Us Products Working at Napp Partnering Education Media Contact Napp products We provide prescription only medicines for respiratory diseases, inflammatory conditions, pain management, cancer, diabetes and cardiovascular conditions. To access our product pages please click on the appropriate box below. Please confirm We provide prescription only medicines for respiratory diseases, inflammatory conditions, pain management, cancer, diabetes and cardiovascular conditions. To access our product pages please click on the appropriate box below. I am a UK healthcare professional I am a patient or a member of the public

About Us Products Working at Napp Partnering Education Media Contact NAPP Academy Asthma Training Napp Academy Website Napp Academy The Napp Academy aims to provide high quality training and educational resources to healthcare professionals; supporting them in delivering the best possible care for their patients. Working in partnership highly respected UK education providers, such as Education for Health and Cardiff University, the Napp Academy is able to provide a range of courses and events designed to support healthcare professionals throughout key stages in their careers. Napp academy currently focuses on providing education and resources in the areas of asthma management. In addition to providing training, the Napp Academy also offers bursaries and travel awards for healthcare professionals in partnership with organisations such as the British Lung Foundation. We also sponsor the Primary Care Respiratory Society (PCRS) UK Respiratory Leaders programme and support the Association of Respiratory Nurse Specialists (ARNS) annual conference. Stay connected LEGAL COOKIE POLICY PRIVACY NOTICE REGISTERED COMPANY MODERN SLAVERY STATEMENT TAX STRATEGY GROUP PENSION SCHEME PENSION IMPLEMENTATION STATEMENT STATEMENT OF INVESTMENT PRINCIPLES © 2021 NAPP PHARMACEUTICALS LIMITED. LAST UPDATED: MAY 2019

About Us Products Working at Napp Partnering Education Media Contact News This page is for general Napp news. For press releases approved for communication with medical press and media, please visit our Press Releases page. Our ongoing response to COVID-19 November 5, 2020 Following the recent announcement of a return to lockdown across England, protecting the health of our employees, partners, suppliers, and contractors continues to be our priority at Napp. Since the outbreak of the virus, Napp has taken all precautions and steps to ensure our supply chain remains robust, and that provision … READ MORE Latest statement from Napp Pharmaceuticals on COVID-19 May 15, 2020 Napp recognised for unique workplace culture with 2020 Great Place to Work® national achievement. April 30, 2020 Type 2 Diabetics miss out on a recommended annual kidney test which can signal irreversible damage that may lead to fatal complications, survey reveals February 20, 2020 VIEW ALL NEWS Stay connected LEGAL COOKIE POLICY PRIVACY NOTICE REGISTERED COMPANY MODERN SLAVERY STATEMENT TAX STRATEGY GROUP PENSION SCHEME PENSION IMPLEMENTATION STATEMENT STATEMENT OF INVESTMENT PRINCIPLES © 2021 NAPP PHARMACEUTICALS LIMITED. LAST UPDATED: MAY 2019